bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.09.22.677785

Dual effects of nicotinamide on aging-related arrhythmia: protective at low dose, proarrhythmic at high doses

Hu, L.·Hu, Y.·Qi, X.·van Rinsum, A.·Keijer, J.·Zhang, D.
View original source ↗Export metadata ↓

Abstract

BackgroundCardiac arrhythmia and dysfunction progressively increase with age, both of which are closely associated with a decline in NAD+. Supplementation with nicotinamide (NAM), a critical NAD+ precursor, has shown protection in experimental models of aging-related cardiac diseases, including atrial fibrillation (AF) and heart failure, especially heart failure with preserved ejection fraction. With the potential rise of NAM in treatment of various cardiometabolic diseases, its dose-dependent cardiac-specific adverse effects and underlying mechanisms warrant investigation. MethodsThe effects of NAM on aging-related arrhythmia and cardiac dysfunction were assessed using ex vivo Langendorff mouse hearts and adult Drosophila heart preparations. Different doses of NAM (10-100 mM) were tested for their impact on the contractility of HL-1 cardiomyocytes, lifespan and cardiac function of Drosophila, as well as arrhythmia susceptibility of ex vivo mouse hearts. Acetylation of sarcoplasmic/endoplasmic reticulum Ca{superscript 2} ATPase 2a (SERCA2a) was measured by immunoprecipitation followed by Western blotting. ResultsAcute perfusion with 10 mM NAM had limited influence on aging-related AF susceptibility in ex vivo mouse hearts. Short-term dietary intervention with 10 mM NAM in late-life protected against aging-induced cardiac arrhythmia and contractile dysfunction exclusively in male Drosophila. In contrast, life-long exposure or NAM concentrations above 20 mM led to dose-dependent adverse cardiac effects, including impaired contractility in HL-1 cardiomyocyte and shortened lifespan in Drosophila, with increased arrhythmia observed in both models. In ex vivo mouse hearts, 100 mM NAM increased SERCA2a acetylation, suggesting inhibition of sirtuin1 and impaired calcium handling, which likely underlies the observed effects of high-dose NAM on arrhythmia and cardiac dysfunction. ConclusionsNAM exhibits a narrow therapeutic window in aging-related cardiac dysfunction and arrhythmia, with its efficacy highly dependent on dose, duration, and biological context. While a moderate dose in late-life may be protective, chronic or excessive intake of NAM can induce arrythmia and impair cardiac function, likely through disruption of the SERCA2a activity. These findings underscore the importance of cautious and context-specific application of NAM in clinical settings.

Source connections

Explore related subjects

physiologyPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hu, L., Hu, Y., Qi, X., van Rinsum, A., Keijer, J., Zhang, D.. 2025-09-24. Dual effects of nicotinamide on aging-related arrhythmia: protective at low dose, proarrhythmic at high doses. https://doi.org/10.1101/2025.09.22.677785

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗
bioRxiv2026

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗
bioRxiv2026

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗